Condition: Sudden Unexplained Infant Death · Apnea of Newborn · Newborn Morbidity · Sponsor: Guilherme Sant'Anna, MD
The goals of this observational study is to assess whether a new advanced wireless skin sensor vital sign monitoring system can effectively monitor the vital signs of healthy newborn infants (≥ 35 weeks gestational age). The main aims of this Study are to: 1. Assess feasibility 2. Evaluate safety 3. Determine accuracy of the wireless monitoring system, compared to the standard of care wired vital sign monitoring system, immediately after delivery and for the first 2h of age in the obstetrical center under unsupervised parents' care. The newborn infants participating in the Study will have both vital sign monitoring systems placed on their chest and limb. Their vital signs will be monitored for 2h consecutively.
This description comes directly from the study's public registry record.
Guilherme Sant´Anna, MD, PhD · 514-934-1934 · guilherme.santanna@mcgill.ca
Alyssa Maximov, BSc · 514-934-1934 · alyssa.maximov@muhc.mcgill.ca
Always discuss trial participation with your own doctor first.
| Hospital Universitário da Universidade Estadual de Londrina | Londrina, Paraná, Brazil | Not Yet Recruiting |
| Montreal Children's Hospital | Montreal, Quebec, Canada | Recruiting |
| Royal Victoria Hospital | Montreal, Quebec, Canada | Recruiting |
| Nuovo Ospedale degli Infermi | Ponderano, BI, Italy | Not Yet Recruiting |
| Lucerne Cantonal Hospital | Lucerne, Canton of Lucerne, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06693817